Healthcare sector | Medical Instruments & Supplies industry
| Price | $125.36 |
|---|---|
| Shares Outstanding | 24.69M |
| All-Time Low | $3.00 |
| 52-Week Low | $107.00 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-29.81 |
| Net Tangible Assets / Share | $0 |
| Shares Outstanding Ave Change (Annual) | 4.83% |
| Shares Δ YoY | 1.56% |
| Avg CA Burn (Annual %) | 12.29% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | -4.37% (as of 3-8-2026) |
| Max Earning Power / Share | $22.26 |
|---|---|
| Adjusted Earning Power |
$-6.07
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.64%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 229.6M (as of 3-8-2026) |
| Avg EBITDA (5Q) | 77.2M (as of 3-8-2026) |
| Avg Net Income (5Y) | -29.6M (as of 3-8-2026) |
| Avg Net Income (5Q) | -4.6M (as of 3-8-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 3-8-2026 |
| Net Income Positive | No | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $-0.38 | -9.5M ($-9,488,000) | 24.7M (24,688,000) |
| 2025-09-30 | Quarterly | $-1.47 | -36.3M ($-36,344,000) | 24.7M (24,685,658) |
| 2025-06-30 | Quarterly | $-3.41 | -84.2M ($-84,153,000) | 24.7M (24,685,000) |
| 2025-03-31 | Quarterly | $-7.48 | -184.1M ($-184,091,000) | 24.6M (24,611,000) |
| 2024-12-31 | Quarterly | $-8.50 | -208.3M ($-208,326,000) | 24.5M (24,517,000) |
| 2024-12-31 | Annual | $-8.50 | -208.3M ($-208,326,000) | 24.5M (24,517,000) |
| 2024-09-30 | Quarterly | $-8.81 | -215.5M ($-215,529,000) | 24.5M (24,459,000) |
| 2023-12-31 | Annual | $-9.10 | -219.6M ($-219,624,000) | 24.1M (24,141,000) |
| 2022-12-31 | Annual | $-14.26 | -342.1M ($-342,096,000) | 24M (23,993,000) |
| 2021-12-31 | Annual | $65.05 | 1.4B ($1,384,281,000) | 21.3M (21,280,000) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 2.4B ($2,382,046,000) |
| 2023-12-31 | 2.3B ($2,259,126,000) |
| 2022-12-31 | 2.3B ($2,279,997,000) |
| 2021-12-31 | 1.3B ($1,316,308,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-03 | 24,690,275 | +3,615 |
Latest short-interest change: 1,123,583 shares (5.41% of float) | Days to cover: 3.80
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 1,123,583 shares | +105,375 | +10.35% |
| 2026-02-27 | 1,018,208 shares | -122,497 | -10.74% |
| 2026-02-11 | 1,140,705 shares | -7,769 | -0.68% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.